FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207079129> ?p ?o ?g. }

• W4207079129 endingPage "1035" @default.
• W4207079129 startingPage "1023" @default.
• W4207079129 abstract "The transcription factor hypoxia-inducible factor 1 (HIF1) is an important driver of cancer and is therefore an attractive drug target. Acriflavine (ACF) has been suggested to inhibit HIF1, but its mechanism of action is unknown. Here we investigated the interaction of ACF with DNA and long non-coding RNAs (lncRNAs) and its function in human endothelial cells. ACF promoted apoptosis and reduced proliferation, network formation, and angiogenic capacity. It also induced changes in gene expression, as determined by RNA sequencing (RNA-seq), which could not be attributed to specific inhibition of HIF1. A similar response was observed in murine lung endothelial cells. Although ACF increased and decreased a similar number of protein-coding genes, lncRNAs were preferentially upregulated under normoxic and hypoxic conditions. An assay for transposase accessibility with subsequent DNA sequencing (ATAC-seq) demonstrated that ACF induced strong changes in chromatin accessibility at lncRNA promoters. Immunofluorescence showed displacement of DNA:RNA hybrids. Such effects might be due to ACF-mediated topoisomerase inhibition, which was indeed the case, as reflected by DNA unwinding assays. Comparison with other acridine derivatives and topoisomerase inhibitors suggested that the specific function of ACF is an effect of acridinium-class compounds. This study demonstrates that ACF inhibits topoisomerases rather than HIF specifically and that it elicits a unique expression response of lncRNAs. The transcription factor hypoxia-inducible factor 1 (HIF1) is an important driver of cancer and is therefore an attractive drug target. Acriflavine (ACF) has been suggested to inhibit HIF1, but its mechanism of action is unknown. Here we investigated the interaction of ACF with DNA and long non-coding RNAs (lncRNAs) and its function in human endothelial cells. ACF promoted apoptosis and reduced proliferation, network formation, and angiogenic capacity. It also induced changes in gene expression, as determined by RNA sequencing (RNA-seq), which could not be attributed to specific inhibition of HIF1. A similar response was observed in murine lung endothelial cells. Although ACF increased and decreased a similar number of protein-coding genes, lncRNAs were preferentially upregulated under normoxic and hypoxic conditions. An assay for transposase accessibility with subsequent DNA sequencing (ATAC-seq) demonstrated that ACF induced strong changes in chromatin accessibility at lncRNA promoters. Immunofluorescence showed displacement of DNA:RNA hybrids. Such effects might be due to ACF-mediated topoisomerase inhibition, which was indeed the case, as reflected by DNA unwinding assays. Comparison with other acridine derivatives and topoisomerase inhibitors suggested that the specific function of ACF is an effect of acridinium-class compounds. This study demonstrates that ACF inhibits topoisomerases rather than HIF specifically and that it elicits a unique expression response of lncRNAs." @default.
• W4207079129 created "2022-01-26" @default.
• W4207079129 creator A5001967997 @default.
• W4207079129 creator A5002124394 @default.
• W4207079129 creator A5013336817 @default.
• W4207079129 creator A5020736698 @default.
• W4207079129 creator A5024297412 @default.
• W4207079129 creator A5036099552 @default.
• W4207079129 creator A5038168057 @default.
• W4207079129 creator A5038321079 @default.
• W4207079129 creator A5063786539 @default.
• W4207079129 creator A5072416432 @default.
• W4207079129 creator A5073963629 @default.
• W4207079129 creator A5082251197 @default.
• W4207079129 creator A5085044803 @default.
• W4207079129 date "2022-03-01" @default.
• W4207079129 modified "2023-09-30" @default.
• W4207079129 title "DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells" @default.
• W4207079129 cites W1964569439 @default.
• W4207079129 cites W1967936457 @default.
• W4207079129 cites W1981332920 @default.
• W4207079129 cites W1982767237 @default.
• W4207079129 cites W1983338915 @default.
• W4207079129 cites W1989540449 @default.
• W4207079129 cites W1994944745 @default.
• W4207079129 cites W2004941068 @default.
• W4207079129 cites W2021341670 @default.
• W4207079129 cites W2027847170 @default.
• W4207079129 cites W2032538372 @default.
• W4207079129 cites W2033167804 @default.
• W4207079129 cites W2048724765 @default.
• W4207079129 cites W2056367986 @default.
• W4207079129 cites W2067878166 @default.
• W4207079129 cites W2070498380 @default.
• W4207079129 cites W2082478000 @default.
• W4207079129 cites W2086034451 @default.
• W4207079129 cites W2090637879 @default.
• W4207079129 cites W2092467693 @default.
• W4207079129 cites W2092638438 @default.
• W4207079129 cites W2103394904 @default.
• W4207079129 cites W2110252008 @default.
• W4207079129 cites W2110289461 @default.
• W4207079129 cites W2117757143 @default.
• W4207079129 cites W2117920043 @default.
• W4207079129 cites W2129680066 @default.
• W4207079129 cites W2131271579 @default.
• W4207079129 cites W2138207763 @default.
• W4207079129 cites W2145701907 @default.
• W4207079129 cites W2155120713 @default.
• W4207079129 cites W2157945371 @default.
• W4207079129 cites W2168215545 @default.
• W4207079129 cites W2169456326 @default.
• W4207079129 cites W2171564701 @default.
• W4207079129 cites W2179438025 @default.
• W4207079129 cites W2190244915 @default.
• W4207079129 cites W2260506919 @default.
• W4207079129 cites W2272847931 @default.
• W4207079129 cites W2320807456 @default.
• W4207079129 cites W2341539131 @default.
• W4207079129 cites W2342510238 @default.
• W4207079129 cites W2343246275 @default.
• W4207079129 cites W2527342240 @default.
• W4207079129 cites W2560534389 @default.
• W4207079129 cites W2585108626 @default.
• W4207079129 cites W2766320516 @default.
• W4207079129 cites W2771049305 @default.
• W4207079129 cites W2800726348 @default.
• W4207079129 cites W2801246231 @default.
• W4207079129 cites W2808919170 @default.
• W4207079129 cites W2901274238 @default.
• W4207079129 cites W2934457987 @default.
• W4207079129 cites W2950789731 @default.
• W4207079129 cites W2975196800 @default.
• W4207079129 cites W3115880421 @default.
• W4207079129 cites W3119810684 @default.
• W4207079129 cites W3124207194 @default.
• W4207079129 cites W3136918052 @default.
• W4207079129 cites W4213105243 @default.
• W4207079129 doi "https://doi.org/10.1016/j.omtn.2022.01.016" @default.
• W4207079129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35228897" @default.
• W4207079129 hasPublicationYear "2022" @default.
• W4207079129 type Work @default.
• W4207079129 citedByCount "5" @default.
• W4207079129 countsByYear W42070791292022 @default.
• W4207079129 countsByYear W42070791292023 @default.
• W4207079129 crossrefType "journal-article" @default.
• W4207079129 hasAuthorship W4207079129A5001967997 @default.
• W4207079129 hasAuthorship W4207079129A5002124394 @default.
• W4207079129 hasAuthorship W4207079129A5013336817 @default.
• W4207079129 hasAuthorship W4207079129A5020736698 @default.
• W4207079129 hasAuthorship W4207079129A5024297412 @default.
• W4207079129 hasAuthorship W4207079129A5036099552 @default.
• W4207079129 hasAuthorship W4207079129A5038168057 @default.
• W4207079129 hasAuthorship W4207079129A5038321079 @default.
• W4207079129 hasAuthorship W4207079129A5063786539 @default.
• W4207079129 hasAuthorship W4207079129A5072416432 @default.
• W4207079129 hasAuthorship W4207079129A5073963629 @default.
• W4207079129 hasAuthorship W4207079129A5082251197 @default.

• next